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Abstract
Objective: Accurate identification and localization of cortical gray matter (CGM) lesions in MS is important when
determining their clinical relevance. Double inversion recovery (DIR) scans have been widely used to detect MS CGM lesions.
Phase sensitive inversion recovery (PSIR) scans have a higher signal to noise, and can therefore be obtained at a higher
resolution within clinically acceptable times. This enables detection of more CGM lesions depicting a clearer cortical and
juxtacortical anatomy. In this study, we systematically investigated if the use of high resolution PSIR scans changes the
classification of CGM lesions, when compared with standard resolution DIR scans.
Methods: 60 patients [30 RR(Relapsing remitting) and 15 each with PP(Primary progressive) and SP(Secondary progressive)
MS] were scanned on a 3T Philips Achieva MRI scanner. Images acquired included DIR (16163 mm resolution) and PSIR
(0.560.562 mm). CGM lesions were detected and classified on DIR as intracortical (IC) or leucocortical (LC). We then
examined these lesions on corresponding slices of the high resolution PSIR scans and categorized them as IC, LC,
Juxtacortical white matter (JC-WM, abutting but not entering cortex) and other white matter (WM, not juxtacortical).
Classifications using both scans were noted.
Results: 282 IC and 483 LC were identified on DIR. Of the IC lesions, 61% were confirmed as IC on PSIR, 35.5% were
reclassified as LC and 3.5% as JC-WM or other WM only. Of the LC DIR lesions, 43.9% were confirmed at LC on PSIR, 16.1%
were reclassified as IC and 40% as JC-WM or other WM only. Overall, 50% (381/765) of CGM lesions seen on DIR were
reclassified, and 26.5% (203/765) affected WM only.
Conclusions: When compared with higher resolution PSIR, a significant proportion of lesions classified as involving CGM on
DIR appear to either contain more white matter than expected or to not involve CGM at all.
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Introduction
Recent advances in imaging techniques have allowed the in vivo
detection of multiple sclerosis (MS) cortical gray matter (CGM)
lesions which were previously only observed histopathologically.
Double inversion recovery (DIR) [1–4] has been most extensively
used to study CGM lesions in vivo, and it has been shown that
accrual of CGM lesions relates to disability in established MS
[2,4,5] and their presence may also improve the specificity of
current MS MRI diagnostic criteria [1–3]. However, a recent
combined histopathology and MRI study has shown that even
with the use of 3D DIR only 17% CGM lesions were detected
prospectively [6].
MS cortical GM lesions have been histo-pathologically sub-
classified based on (i) location i.e. relative to GM/CSF and GM/
WM boundary and (ii) morphology. Based on their location they
have been sub-classified as abutting the cerebrospinal fluid (CSF)
but not extending through the whole cortical ribbon, traversing
the full thickness of the cortex from the CSF to WM interfaces, or
confined to the centre of the cortex (not touching either the CSF
or WM boundaries) [1,2,4,7,8].
Using the standard resolution 2D DIR sequences that have
been acquired in many published studies of MS to date [1,3,4,8–
12], it is difficult to reliably identify subtypes of GM lesions [1–4].
In particular, juxtacortical WM lesions (JC-WM) - one of the
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subtypes of WM lesions that count towards MS MRI diagnostic
criteria [2,4,5] have the potential to be confused with mixed GM-
WM lesions. Due to the intrinsically low signal to noise of DIR, it
is difficult to increase the resolution beyond that already obtained
while maintaining clinically acceptable scan times. In contrast,
phase sensitive inversion recovery (PSIR) scans can be acquired at
significantly higher resolution within clinically feasible times, and
recent work has suggested that on higher resolution PSIR scans it
is possible to detect about three times as many CGM lesions. In
addition, when compared with standard resolution DIR, the
cortical ribbon and adjacent WM are more distinct on PSIR,
allowing juxtacortical WM (JC-WM) lesions to be separated from
mixed GM-WM lesions [3]. This raises the possibility that some
lesions identified as purely or partly involving CGM on DIR may
actually contain WM, or be entirely within the juxtacortical WM.
This has important implications when considering the clinical
relevance of CGM relative to JC-WM lesions, and it is possible
that a significant proportion of lesions classified as CGM on DIR
may contain substantially more WM than expected.
CGM lesions have also been divided into subtypes based on
morphology, on DIR [1–3] and PSIR [1,2,4,6,7]. More recent
work has suggested that curvilinear lesions may help differentiate
age-associated GM lesions from those due to neuroinflammation
[1,2,4,7,8].
We hypothesized that the higher resolution of PSIR will
improve the classification of CGM lesions beyond that possible
using standard resolution 2D DIR in clinically acceptable scanning
times. A better understanding of the extent and location of gray
matter involvement and possibly the morphology of lesions will
improve the specificity of observations made in the context of MS
and reduce the noise while interpreting correlations between
CGM lesion and parameters of cognitive and clinical parameters.
Different groups have investigated the roles of DIR [4,8,9],
PSIR [1,3,10–12] and a combination of DIR and PSIR in
improving lesion detection; [13,14]. However, an in vivo assess-
ment of the accuracy of CGM lesion localization using the widely
reported standard 2D DIR sequence has not been previously
undertaken. Having acquired high resolution PSIR and standard
resolution DIR images in a cohort of 60 MS patients, we now
compare the location of CGM lesions defined on DIR with their
location defined on the higher resolution PSIR images that
provide a considerably improved anatomical definition of the
cortex and adjacent white matter.
In this study, we determined if lesions seen on DIR images were
similarly classified in terms of location and morphology on higher
resolution PSIR scans.
Materials and Methods
1.1 Participants
A cohort of 60 patients {30 relapsing-remitting (RR) MS, 15
each with primary (PP) and secondary progressive (SP) MS} had
been recruited for earlier work that showed a quantitative
improvement in CGM lesion detection using PSIR (vs. 2D
DIR). [1]. We now studied this cohort to investigate the change in
classification of lesions across both these scans This work was
reviewed and approved by the NRES Committee London-Queen
Square. All patients gave written informed consent.
1.2 Image Acquisition
DIR, PSIR and fluid attenuated inversion recovery (FLAIR)
scans were acquired on a 3T Achieva TX system (Philips
healthcare, Best, The Netherlands) with a 32-channel coil(Table 1).
1.3 Image Analysis
CGM lesions were identified and classified independently on
DIR, using FLAIR as a reference when needed. Lesion marking
and sub-classification was performed as per published guidelines
[1,8]).
CGM lesions were first identified and localized on DIR. We
then identified the same lesions, on corresponding slices of the
high resolution PSIR scans and classified them based on their
location as it appeared on the PSIR scan. Classifications on both
DIR and PSIR were noted. All lesions were marked under
supervision of senior raters (including an experienced neuro-
radiologist [TY]). Intra-rater and Inter-rater reproducibility for
this process has been shown to be good in earlier published work.
[1].
On DIR, the lesions were classified as intracortical (IC, only
involving GM) or leucocortical (LC; mixed GM-WM lesions). JC-
WM lesions could not be separated from the adjacent cortex using
DIR, but these could be distinguished using PSIR, owing to the
improved grey –white contrast and better SNR, on the higher
resolution PSIR. The CGM lesions detected on DIR (IC or LC)
were thus classified on PSIR scans in to one of 4 categories: IC,
LC, JC-WM lesions (WM lesions abutting but not entering the
cortex), or other WM lesions (non-JC). Based on their morphol-
ogy, cortical lesions were sub-classified by shape as curvilinear
(lesions that follow the contour of sulcal and gyral folds), oval or
wedge shaped [2].
Classification of DIR visible CGM lesion location lesions was
first performed and the noted using DIR sequence and then – for
each lesion, the corresponding classification on PSIR was noted.
We noted changes in classification from either IC/LC on DIR to
IC/LC/JC or WM on PSIR.
Results
765 CGM lesions were marked on DIR, 282 of these were IC
and 483 LC. Of the 282 IC lesions, 172 (61%) were confirmed as
IC on PSIR, and 110(39%) were reclassified (100 LC [35.5%], 8
JC-WM [2.8%] 2 Non-JC WM (0.7%)). Of the 483 LC DIR
lesions, 212 (43.9%) were confirmed as LC on PSIR, and 271
Table 1. Acquisition parameters.
Resolution (mm) FOV (mm2) TR (ms) TE (ms) TI (ms) Slices SENSE Time (mins)
FLAIR 16163 2406180 8000 125 2400 50 1.3 3.4
DIR 16163 2406180 16000 9.9 3400/325 50 2 4.16
PSIR 0.560.562 2406180 7306 13 400 75 – 11.26
FOV= field of view, TR = repetition time, TE = echo time, TI = inversion time, SENSE = sensitivity encoding factor.
doi:10.1371/journal.pone.0078879.t001
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(56.1%) were reclassified (78 IC [16.1%], 155 JC-WM, 38 WM
[together totaling 40%]). (Table 2; Figure 1).
Morphologically, on DIR, 665 of CGM lesions were initially
classified as oval, 59 curvilinear and 41 wedge shaped. Using PSIR
148/765 (19.3%) were reclassified (see Table 3). The most striking
difference was the higher number of lesions classified as curvilinear
on PSIR than on DIR.
Discussion
In this study we found that MS lesions reported to involve the
CGM on DIR were often reclassified in a different anatomical
location when viewed on a higher resolution PSIR sequence.
Specifically, 39% (110/282) lesions thought to only involve CGM
on DIR (i.e. IC lesions) where noted to extend into WM on PSIR,
and of the mixed GM-WM lesions on DIR (i.e. LC) about 56%
(271/483) were reclassified on PSIR, with about 40% (193/483)
classified as being purely in the WM.
A recent combined histopathological and MRI study reported
that 90% of CGM lesions seen on a high resolution 3D DIR scan
(using a scan resolution of 1.1 by 1.1 by 1.3 mm, which is higher
than those used in the present study and that have commonly been
used in previous in vivo studies) were histopathologically confirmed
Table 2. Change of classification of lesions from DIR to PSIR
(based on lesion type).
As subsequently seen on PSIR
IC LC JC WM
On DIR IC (N =282) 172(61) 100(35.5) 8(2.8) 2(0.7)
LC (N=483) 78 (16.1) 212 (43.9) 155(32.1) 38 (7.9)
[number (percentage)] Each row corresponds to a lesion type seen on DIR, and
each column how the same lesion was classified on PSIR. E.g. of the IC lesions so
classified on DIR, 60% remained so on PSIR.
doi:10.1371/journal.pone.0078879.t002
Figure 1. Corresponding DIR and PSIR images showing change of classification of CGM lesions. DIR LC lesions (blocked chevron) in panel
A, appear as JC-WM lesions on PSIR in panel B; DIR LC lesion in panel C is seen to be a pure IC lesion on PSIR in panel D; DIR LC lesion (blocked
chevron) and IC lesion (open chevron) in panel E appear as JC WM and LC on PSIR respectively, in panel F.
doi:10.1371/journal.pone.0078879.g001
Table 3. Change of classification of lesions from DIR to PSIR
(based on morphology of lesions).
As subsequently seen on PSIR
Oval Wedge Curvilinear
On DIR Oval (N = 665) 523 (78.6) 26 (3.9) 116 (17.4)
Wedge (N= 41) 0 30 (73.2) 11(26.8)
Curvilinear (N = 59) 5 (8.5) 0 54 (91.5)
[number (percentage)] Each row corresponds to a lesion type seen on DIR, and
each column how the same lesion was classified on PSIR. E.g. of the IC lesions so
classified on DIR, 60% remained so on PSIR.
doi:10.1371/journal.pone.0078879.t003
MS Cortical Lesions
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[6]. However, the present study suggests that at the resolution that
has been more often employed in clinical DIR studies published to
date (16163 mm) a larger proportion of DIR identified CGM
lesions may actually be false positives.
In a previous study where CGM lesions were marked
independently on DIR and high resolution PSIR, about three
times more CGM lesions were detected on PSIR [1]. However,
the high frequency in the present study with which DIR CGM
lesions were reclassified as WM lesions suggests that the increase in
true CGM lesion detection on PSIR may be even higher, perhaps
about 6 times that of DIR.
Not surprisingly, DIR-classified LC lesions were more likely
than IC lesions to be reclassified as being entirely in the WM (40%
and 3.5% respectively). JC-WM lesions seen on conventional T2-
weighted and FLAIR sequences are included in the current
McDonald 2010 diagnostic criteria [5] but it has been suggested
that intracortical lesions seen on DIR may also have a role in
improving the accuracy of MRI diagnostic criteria for MS. [3,9].
Noting that a significant proportion of lesions classified as
involving CGM on DIR may actually be JC WM lesions, this
raises the question of whether more accurate classification of
CGM lesions would enhance their role in diagnostic criteria.
Prospective studies following CIS patients who have had high
resolution PSIR and DIR scans at presentation could address this
question. From this work we also cannot determine if it is
resolution or contrast that most influences the classification of
lesions on DIR or PSIR. Pragmatically, it is not currently possible
(due to intrinsically low signal to noise of DIR) to increase the
resolution of DIR to match that of the PSIR scan used in this study
while remaining within clinically acceptable scan times.
Cognitive impairment is seen in about 40–60% patients with
MS [15,16] and previous work using standard resolution DIR has
demonstrated correlations between cortical lesion load and
measures of cognitive and clinical disability [14]. These data
support a role for lesions in or near the cortex in determining
clinical outcomes [14]. A higher cortical lesion number has been
reported in those MS patients who are cognitively impaired and
cortical lesion volume has been found to be an independent
predictor [17]. Further, a study using FLAIR scans reported an
association of cognitive impairment with JC-WM lesions [18].
Thus, accurate classification and quantification of CGM and JC-
WM lesions is key in studying whether this impairment is driven
by pathology in the cortex, juxtacortical WM or both regions. The
potentially limited accuracy of CGM classification on DIR again
raises questions about the actual contribution of CGM and JC-
WM lesions to physical and cognitive deficits, and this maybe
worth revisiting with a combination of methods such as high
resolution PSIR and DIR.
Consensus recommendations for marking CGM lesions on DIR
were published in 2010 [8]. While both 2D DIR and 3D DIR
have improved the detection of cortical lesions, PSIR (voxel size
0.5 mm3; 0.560.562 mm) provides a greater resolution than both
the commonly used 2D DIR (voxel 3 mm3; 16163 mm i.e. Six
times higher] and 3D DIR (voxel 1–2 mm3) [2–4 times higher].
DIR has a low SNR. Further, as scan times are proportional to the
inverse of the square root of SNR, any attempt to get similar sub-
millimeter in plane resolution and to maintain the same SNR
using DIR will take a prolonged time that is usually not acceptable
for clinical purposes. It is for this reason that a direct comparison
with both scans at a similar resolution is not practical in a clinical
setting. PSIR has a higher SNR and provides an improved
anatomical definition with high in-plane resolution (0.560.5 mm)
in clinically acceptable times. [1] Nevertheless, there are now
widely available 3D DIR sequences that have better resolution
than the standard 2D DIR sequence used in the present study and
a comparison of these sequences with high resolution PSIR could
usefully be undertaken.
In our earlier study, we identified curvilinear lesions in 36% of
people with MS using DIR and in 85% using PSIR, while no such
lesions were seen in healthy controls [3]. Investigation is required
in people with other neurological conditions to determine the
specificity of such lesions for MS, but these findings do suggest a
potential role in diagnosis. Given differences in the apparent
frequency of curvilinear lesion on DIR and PSIR, we looked at the
consistency of CGM lesion morphological classification between
DIR and PSIR, and found that 27% of the wedge shaped and
17% of the oval shaped lesions were reclassified as curvilinear on
PSIR. This suggests that, at least in part, the apparently higher
number of curvilinear lesions seen on PSIR when compared with
DIR may be due to greater accuracy. Given the contrasting
finding between patients and controls, the lesion morphology may
also help in the diagnosis of MS when it is suspected but not
confirmed.
In conclusion, we have found that a significant proportion of
lesions thought to involve CGM on standard resolution DIR
images are reclassified as WM lesions when viewed on a higher
resolution PSIR sequence. While DIR has improved cortical lesion
detection [4,9,10], in addition to increasing the number of CGM
lesions identified, PSIR is also likely to improve the accuracy of
CGM lesion classification.
In future a multimodal approach, using multiple scans like DIR
(especially higher resolution 3D DIR sequences) and PSIR, may
help with CGM lesion detection and localization [13]; PSIR
however provides useful additional information regarding the
classification of lesion location and morphology. The findings of
this work warrant attention in future studies investigating the role
of CGM lesions in MS diagnostic criteria and in investigating how
CGM and adjacent WM lesion location and morphology relate to
cognitive or neurological function. While post mortem verification
of cortical lesions using DIR has recently been reported [6,19], a
similar post mortem study to PSIR visible cortical lesions should
provide an improved understanding of our in vivo results.
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